Research & Development  

Scientific Overview

Scientific Presentations

Scientists 


Clinical Studies

Clinical Trial Participation

Clinical Trial Sites


Pre-Clinical Research
Product Pipeline

Scientific Reports

   
Scientific Presentations  
 

Upcoming Events:

No upcoming events scheduled. Check back soon.

Past Events:

In Business Las Vegas to honor
Dr. Thomas J. Stegmann, MD, PhD

"Health Care Headliners: Saluting Individuals and organizations who do extraordinary things in the health care industry"
Thursday, April 10, 2008, 6:00 - 8:00 PM
Platinum Hotel, Las Vegas, NV

Lecture of Dr. Thomas J. Stegmann, MD, PhD
"Angiogenesis: Perfusion is All That Matters"
Sunday, March 09, 2008, 08:00 PM.
Stuko Convention Center, Tel Aviv, Israel

American Heart Association’s 3rd Annual “Go Red for Women” Luncheon
Four Seasons Hotel, Las Vegas
Thursday, February 27, 2008

Regenerative Medicine Organization 5th Annual Conference
The Venetian Las Vegas
February 17-19, 2008

Department of Biomedical Sciences, Florida State University
Tallahassee, Florida
November 1, 2007
Presentation Title: “Angiogenesis – a New Principle of Treatment for Cardiovascular Disease” by Dr. Thomas Stegmann
Presentation Date: November 1st

From left to right: Cristina Russo (MOB graduate student, Co-Pi with Dr. Marcia Fenley and Michael Blaber), Zhe Xu (COM graduate student), Hyesook Yoon (Chemistry & Biochemistry graduate student), Prof. Dr. Thomas Stegmann, Dr. Michael Blaber, Dr. Hugh Nymeyer (professor of Chemistry & Biochemistry and Computational Sciences collaborator), Dr. Jihun Lee (postdoctoral researcher), Liam Longo (undergraduate researcher).


 

 

 

Use of this site constitutes agreement to our Terms and Conditions
and Privacy Policy. Site Design and Contents © 2008 CardioVascular BioTherapeutics, Inc. All Rights Reserved.

Some content on this site requires the free Adobe Reader.

 

12/11/2008
CVBT Opens Two Additional Sites for Patient Enrollment for Phase II Heart Trial


11/25/2008
CVBT Doses First Patient in its Phase II Clinical Trial for Severe Coronary Heart Disease


11/13/2008
CVBT Closes Clinical Development Agreement for Coronary Heart Disease Drug Candidate


9/9/2008
CVBT Announces First Site to Begin Patient Enrollment for Its Phase II Heart Trial